Glucotrack earnings were -$15.9M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest GCTK earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$3.8M, down 12% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, GCTK reported annual earnings of -$19.4M, with -14.2% growth. The next GCTK earnings date is Nov 12, 2026.
On GCTK's earnings call on Aug 13, 2026, Glucotrack (NASDAQ: GCTK) reported Q2 2026 earnings per share (EPS) of -$11.40, up 92.08% year over year. Total GCTK earnings for the quarter were -$3.81 million. In the same quarter last year, Glucotrack's earnings per share (EPS) was -$144.00.
The next GCTK earnings call is Nov 12, 2026. Add GCTK to your watchlist to be reminded of Glucotrack's next earnings date.
What was GCTK's earnings growth in the past year?
As of Glucotrack's earnings date in Aug 13, 2026, Glucotrack's earnings has grown year over year. GCTK earnings in the past year totalled -$15.95 million.
Is Glucotrack profitable or losing money?
As of the last Glucotrack earnings report, Glucotrack is currently losing money. Glucotrack's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$15.95 million, a 40.43% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.